1Sotoparra H J, Gavina R, Antonelli G, et al. Superiority of three wek vs four week schedule of cisplatin (CDDP)and gemcitabine (GEM) :resuits of a randomized phase H study[J]. Lung Cancer, 2000,29 (Suppl 1 ) :501.
3Schiller J H, Harrington D, Belani C P, et al. Eastern Cooperative Oncology Group : comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med,2002,346(2) :92.
4Armand J P. Docetaxel ( Taxotere ) in the rteatment of non-small-cell Lung cancer(NSGLC) is there a role for a new chmotherapy program [J]. Gan To Kagakv Ryoho,2000,27 ( Suppl 2 ) :223.
5Raez L E, Lilenbaum R. New development in chemotherapy for advanced non-small cell lung ancer [J]. Curr Opin Oncol,2006,18 (2) :156.
6Laskin J J, Sandier A B. First-line treatment for advanced non-amall cell lung cancer [J].Oncology ( Williston Park ) , 2005,19 ( 13 ) : 1671.
7Smit E F, Vanmeerbeeck J P, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer:a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975[J].J Clin Oncol,2003,21 (21) :3909.
3Raez L E, Lilenbaum R. New developments in chemotherapy for advanced non-small cell lung cancer [J]. Curr Opin Oncol,2006,18(2) : 156-161.
4Laskin J J, Sandier A B. First-line treatment for advanced non-small-cell lung cancer [J]. Oncology (Williston Park), 2005,19(13) : 1671-1680.
5Le Chevalier T, Brisgand D, Pujol J L, et al. Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer[J].Bull Cancer, 1996,83 (5) : 385-394.
6Chen C H, ChangW C, Lin M C, et al. Phase Ⅱ study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer(NSCLC) [J]. Lung Cancer, 2002,38( 1 ) :91-96.
7Bretti S, Manzin E, Loddo C, et al. Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase Ⅱ study [J]. Anticancer Res, 2002,2(5):3039-3043.
8Stathopoulos G P, Rigatos S, Malamos N A. Paclitaxel combined with cisplatin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cisplatin [J]. Oncol Rep, 1999,6(4):797-800
9Johnson D H, Chang A Y, Ettinger D S, et al. Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Ontology Group [J]. Ontology (Williston Park),1998,12( 1 Suppl 2) :67-70.
10Schiller J H, Harrington D, Belani C P, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med, 2002,346(2):92-98.
